A significant breakthrough in cancer research is emerging with the use of nanobodies to re-engage damaged p53. This vital tumor inhibitor protein is frequently inactivated in several types of tumors, resulting https://tinybookmarks.com/story21910433/mini-antibodies-reactivate-p53-a-new-approach-for-tumor-therapy